Alexion Pharmaceuticals Inc (ALXN)

182.50 0.00 (0.00%)
Closed USD Disclaimer

ALXN Balance Sheet

Total Current Assets
Name
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
6,452.60 5,833 5,067.80 5,367.90 4,870.20
Cash and Short Term Investments 3,469.30 2,999.40 2,296.90 2,851.80 2,362.80
Cash - - - - -
Cash & Equivalents 3,429.60 2,964.50 2,268 2,825 2,315
Short Term Investments 39.70 34.90 28.90 26.80 47.80
Total Receivables, Net 1,473 1,409.30 1,437.10 1,372.20 1,345.20
Accounts Receivables - Trade, Net 1,473 1,409.30 1,437.10 1,372.20 1,345.20
Total Inventory 803.90 775.70 729 577.70 586.80
Prepaid Expenses 706.40 648.60 604.80 522.70 522.20
Other Current Assets, Total 43.50 53.20 - - -
18,650.20 18,103 17,548.40 16,703.20 18,148.50
Property/Plant/Equipment, Total - Net 1,461.60 1,461.90 1,434.60 1,406.30 1,363.10
Property/Plant/Equipment, Total - Gross - - - - -
Accumulated Depreciation, Total - - - - -
Goodwill, Net 5,100.10 5,100.10 5,100.70 5,075.20 5,072.10
Intangibles, Net 3,048.30 3,002.40 3,056.60 2,059.70 4,187.60
Long Term Investments - - - - -
Note Receivable - Long Term - - - - -
Other Long Term Assets, Total 2,587.60 2,705.60 2,888.70 2,794.10 2,655.50
Other Assets, Total - - - - -
1,426.20 1,624.70 1,331 1,120.10 1,119.90
Accounts Payable 125.30 118.60 89.20 - -
Payable/Accrued 1,203.30 861.60 862.80 - -
Accrued Expenses 910.70 1,084.70 978.40 - -
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 143.20 142.40 138.60 126.80 126.70
Other Current liabilities, Total 247 279 124.80 131.70 130.40
6,233.40 6,451.80 6,473.50 6,212.40 6,400.70
Total Long Term Debt 2,388.80 2,419.60 2,453.30 2,311.60 2,343.30
Long Term Debt 2,388.80 2,419.60 2,453.30 2,311.60 2,343.30
Capital Lease Obligations - - - - -
Deferred Income Tax 1,639.10 1,632.20 1,818.20 1,946.80 2,113.30
Minority Interest 14.20 - - - -
Other Liabilities, Total 765.10 775.30 871 833.90 824.20
12,416.80 11,651.20 11,074.90 10,490.80 11,747.80
Redeemable Preferred Stock, Total - - - - -
Preferred Stock - Non Redeemable, Net - - - - -
Common Stock, Total 0 0 0 0 0
Additional Paid-In Capital 9,243.30 9,152.90 9,030.40 8,942.40 8,864.90
Retained Earnings (Accumulated Deficit) 5,879.20 5,243.20 4,707.40 4,129.30 5,197.40
Treasury Stock - Common -2,620.50 -2,620.30 -2,543.70 -2,470 -2,213
ESOP Debt Guarantee - - - - -
Unrealized Gain (Loss) 0 0 0 0 -0.30
Other Equity, Total -85.20 -124.60 -119.20 -110.90 -101.20
18,650.20 18,103 17,548.40 16,703.20 18,148.50
220.90 219.50 219 219.10 221.10
- - - - -

* In Millions of USD (except for per share items)

Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.